Follow the ALMIRALL, S.A. stock price and the full management transaction log of the company, a listed issuer based in Spain. Shares are quoted on the ES market, under the authority of CNMV. Operating in the Health Care sector, ALMIRALL, S.A. has logged 20 insider filings. Market capitalisation: €2.4bn. The latest transaction was filed on 22 June 2023 (Purchase). Among the most active insiders: PAOLO CIONINI. All data is openly available.
20
Insider Decl.
n/a
Thresholds
€190,917
5 ops.
Buy Volume
€7m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ALMIRALL, S.A. Buy (bullish), based on 12 analysts. Average price target: €14.58.
30Σ signal
Buys €190,917€7m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,126 of 29,062 companies
52.8
score / 100
Value
47
Quality
59
FCF yld1.5%
Earn yld1.9%
EV/EBITDA11.8x
ROE4.0%
Gross mgn79%
Net mgn4.2%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ALMIRALL, S.A. es una empresa farmacéutica española centrada en el desarrollo de tratamientos dermatológicos y respiratorios. Cotiza en el mercado bursátil español XMAD.